JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2012, 61(6):255-260

Halloysite - interesting nanotubular carrier for drugs

Miloslava Rabišková
Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University

Halloysite is a naturally occurring mineral similar to kaolin, possessing a special particle shape in the form of ultramicroscopic multi-layered hollow cylinders. It is utilizable in many industrial branches and due to its advantages, e.g. biocompatibility, drug entrapment, high mechanical strength and easy natural availability also on the pharmaceutical field and in medicine. It can bind drugs on the surface or inside of tubules and increase drug stability or change its release. Surface of the tubules can be readily modified for the application in drug delivery systems. Halloysite was reported as promising material for bone implants and controlled delivery of biomacromolecules. This review is dealing with pharmaceutical and biomedical usage of this interesting material and is including original experimental work published recently.

Keywords: halloysite; drug entrapment; drug release; drug delivery systems; tissue engineering

Received: November 5, 2012; Accepted: November 14, 2012; Published: June 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rabišková M. Halloysite - interesting nanotubular carrier for drugs. Čes. slov. farm. 2012;61(6):255-260.
Download citation

References

  1. Christie T., Thompson B., Brathwaite B. Mineral commodity report 20. Clays New Zealand Mining. 2000; 27, 26-43.
  2. Adamo P., Violante P. Wilson M. J. Tubular and spheroidal halloysite in pyroclastic deposits in the area of the Roccamonfina volcano (Southern Italy). Geodema 2001; 99, 295-316. Go to original source...
  3. Christie T., Fletcher W. K. Contamination from forestry activities: implications for stream sediment exploration programmes. Journal of Geochemical Exploration 1999; 67, 201-210. Go to original source...
  4. Price R. R., Gaber B. P., Lvov Y. M. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dinucleotide from halloysite. J Microencapsulation 2001; 18(6), 713-722. Go to original source... Go to PubMed...
  5. Joussein B., Petit D., Churchman B., Theng J., Righi S., Delvaux E. Halloysite clay minerals. Clay Miner. 2005; 40, 383-426. Go to original source...
  6. Klimkiewicz R., Drag, E. B. Catalytic activity of carbonaceous deposits in zeolite from halloysite in alcohol conversions. J. Phys. Chem. Solids 2004; 65, 459-464. Go to original source...
  7. Rawtani D., Agrawal Y. K. Multifactorious appliactions of halloysite nanotubes. Rev. Adv. Mater. Sci. 2012; 30, 282-293.
  8. Joussein E., Petit S., Delvaux B. Behavior of halloysite clay under formamide treatment. Applied Clay Science 2007; 35, 17-24. Go to original source...
  9. Levis S. R., Deasy P. B. Characterization of halloysite for use as a microtubular drug delivery system. Int. J. Pharm. 2002; 243, 125-134. Go to original source... Go to PubMed...
  10. Kirkman J. H. Halloysite discs and cylinders. Clay Miner. 1977; 12, 199-216. Go to original source...
  11. Tari G., Bobos I., Gomes C. S. F., Ferreira J. M. F. Modification or surface charge properties during kaolinite to halloysite 7 Å transformation. J. Colloid Interf. Sci. 1999; 210, 360-366. Go to original source... Go to PubMed...
  12. Harrison J. L., Greenburg S. S. Dehydration of fully hydrated halloysite from Lawrence county Indiana. Clay Miner. 1962; 9, 374-377. Go to original source...
  13. Wada K. Lattice expansion of kaolinite minerals by treatment with potassium acetate. Am. Miner. 1961; 46, 78-91.
  14. Carr R. M. Chih H. Complexes of halloysite with organic compounds. Clay Miner. 1971; 9, 153-166. Go to original source...
  15. Kadi S., Lellou S., Marouf-Khelifa K., Schott J., Gener-Batonneau I. Preparation, characterization and application of thermally treated Algerian halloysite. Microporous and Mesoporous Materials 2012; 158, 47-54. Go to original source...
  16. Lu D., Chen H., Wu J., Chan C. M. Direct measurements of the Young's modulus of single halloysite nanotube using a transmission electron microscope with a bending stage. Journal of Nanoscience and Nanotechnology 2011; 9, 7789-7793. Go to original source... Go to PubMed...
  17. White R. D., Bavykin D. V., Waish F. C. The stability of halloysite nanotubes in acidic and alkaline aqueous suspensions. Nanotechnology 2012; 23 (6), DOI: 10. 1088/0957-4484/23/6/065705 Go to original source... Go to PubMed...
  18. Levis S. R., Deasy P. B. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int. J. Pharm. 2003; 253, 145-157. Go to original source... Go to PubMed...
  19. Lvov Y. M., Price R., Gaber B., Ichinose I. Thin film nanofabrication via layer-by-layer adsorption of tubule halloysite, spherical silica, proteins and polycations. Colloids and Surfaces A: Physicochem. Eng. Aspects 2002; 198-200, 375-382. Go to original source...
  20. Kelly H. M., Deasy P. B., Ziaka E., Claffey N. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int. J. Pharm. 2004; 274, 167-183. Go to original source... Go to PubMed...
  21. Viseras M. T., Aguzzi C. Cerezo P., Viseras C., Valenzuela C. Equilibrium and kinetics of 5-aminosalicylic acid adsorption by halloysite. Microporous and Mesoporous Materials 2008; 108, 112-116. Go to original source...
  22. Suh Y. J., Kil D. S., Chung K. S., Abdullayev E., Lvov Y. M., Montagyt D. Natural nanocontainer for the controlled delivery of glycerol as moisturizing agent. Journal of Nanoscience and Nanotechnology 2001; 11(1) 661-665. Go to original source... Go to PubMed...
  23. Forsgren J., Jamstorp E., Bredenberg S., Engqvist H., Strømme M. A ceramic drug delivery vehicle for oral administration of highly potent opioids. J. Pharm. Sc. 2010; 99(1), 219-226. Go to original source... Go to PubMed...
  24. Mitchell M. J., Chen C. S., Ponmudi V., Hughes A. D., King M. R. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J. Controlled Release 2012; 160, 609-617. Go to original source... Go to PubMed...
  25. Zhou W.Y., Guo B., Liu M., Liao R., Rabie B.M., Jia D. Poly(vinylalcohol) halloysite nanotubes bionanocomposite films: Properties and in vitro osteoblasts and fibroblasts response. Journal of Biomedical Materials Research Part A 2010; 93, 1574-1587. Go to original source... Go to PubMed...
  26. Zhang L., Wang T., Liu P. Polyaniline-coated halloysite nanotubes via in situ chemicla polymerazation. Applied Surface Science 2008; 2555, 2091-2097. Go to original source...
  27. Yuan P., Southon P. D., Liu Z., Green M. E. R., Hook J. M., Antill S. J. Kepert C. J. Functionalization of halloysite clay nanotubes by grafting with γ-aminopropyltriethoxysilane. J. Phys. Chem. 2008; 112, 15742-15751. Go to original source...
  28. Mu B., Zhao M., Liu P. Halloysite nanotubes grafted hyperbranched (co)polymers via surface-initiated self- condensing vinyl (co)polymerization. J.Nanopart. Res. 2008; 10, 831-838. Go to original source...
  29. Shi Y. F., Tian Z., Zhang Y., Shen H. B., Jia N. Q. Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides. Nanoscale Research Letters 2011; 6, 608-615. Go to original source... Go to PubMed...
  30. Vergaro V., Abdullayev E., Lvov Y. M., Zeitoun A., Cingolani R., Rinaldi R., Leporatti S. Cytocompability and uptake of halloysite clay nanotubes. Biomacromolecules 2010; 11, 820-826. Go to original source... Go to PubMed...
  31. Cavallaro G., Lazzara G., Milioto S. Dispersions of nanoclays of different shapes into aqueous and solid biopolymeric matrices. Extended physicochemical study. Langmuir 2011; 27(3), 1158-1167. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.